Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases
- PMID: 23865420
- PMCID: PMC3726295
- DOI: 10.1186/1471-2253-13-15
Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases
Abstract
Background: Hyperthermic isolated limb perfusion (HILP) is used for patients with intractable or extensive in-transit metastatic melanoma of the limb to deliver high concentrations of cytotoxic agents to the affected limb and offers a treatment option in a disease stage with a poor prognosis when no treatment is given.
Methods: In a retrospective chart review of 17 cases, we studied the anesthetic and hemodynamic changes during HILP and its management.
Results: HILP was well tolerated except in one case that is described herein. We present summary data of all cases undergoing upper and lower limb perfusion, discuss our current clinical practice of preoperative, perioperative and intraoperative patient care including the management of HILP circuit.
Conclusion: HILP is a challenging procedure, and requires a team effort including the surgical team, anesthesia care providers, perfusionists and nurses. Intraoperatively, invasive hemodynamic and metabolic monitoring is indispensable to manage significant hemodynamic and metabolic changes due to fluid shifts and release of cytokines.
Figures

Similar articles
-
Multidisciplinary Perioperative Management of Hyperthermic-Isolated Limb Perfusion for Malignant Melanoma: A Case Report.Indian J Surg Oncol. 2021 Dec;12(Suppl 2):371-373. doi: 10.1007/s13193-021-01371-z. Epub 2021 Aug 3. Indian J Surg Oncol. 2021. PMID: 35035175 Free PMC article.
-
A feasibility study of circulating melanoma cells in the perioperative context of hyperthermic isolated limb perfusion (HILP) in 20 patients.Int J Hyperthermia. 2021;38(1):70-78. doi: 10.1080/02656736.2021.1874062. Int J Hyperthermia. 2021. PMID: 33487077
-
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.Ann Surg Oncol. 2008 Aug;15(8):2195-205. doi: 10.1245/s10434-008-9988-9. Epub 2008 Jun 5. Ann Surg Oncol. 2008. PMID: 18528730 Clinical Trial.
-
Hyperthermic isolated limb perfusion in the management of extremity sarcoma.Curr Opin Oncol. 2003 Jul;15(4):300-3. doi: 10.1097/00001622-200307000-00004. Curr Opin Oncol. 2003. PMID: 12874508 Review.
-
Molecular Aspects of the Isolated Limb Infusion Procedure.Biomedicines. 2021 Feb 7;9(2):163. doi: 10.3390/biomedicines9020163. Biomedicines. 2021. PMID: 33562337 Free PMC article. Review.
Cited by
-
Multidisciplinary Perioperative Management of Hyperthermic-Isolated Limb Perfusion for Malignant Melanoma: A Case Report.Indian J Surg Oncol. 2021 Dec;12(Suppl 2):371-373. doi: 10.1007/s13193-021-01371-z. Epub 2021 Aug 3. Indian J Surg Oncol. 2021. PMID: 35035175 Free PMC article.
-
The Use of Regional Anesthesia to Reduce Blood Loss in Isolated Limb Perfusion (ILP)-A Novel Approach.J Clin Med. 2023 Oct 16;12(20):6542. doi: 10.3390/jcm12206542. J Clin Med. 2023. PMID: 37892681 Free PMC article.
-
Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma.Sci Rep. 2020 Aug 6;10(1):13245. doi: 10.1038/s41598-020-70233-5. Sci Rep. 2020. PMID: 32764623 Free PMC article.
-
Clinical characteristics of critically ill cancer patients who are undergoing isolated limb perfusion.Mol Clin Oncol. 2017 Nov;7(5):747-750. doi: 10.3892/mco.2017.1401. Epub 2017 Aug 31. Mol Clin Oncol. 2017. PMID: 29142747 Free PMC article.
References
-
- Schaadt J, Crowley R, Miller D, Kavanah M. Isolated limb perfusion: a literature review. J Extra Corpor Technol. 2002;34:130–143. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources